CALGB 30801
Title:
A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer
Available at:
CoxHealth
Medical
Center,
Springfield,
MO
Mercy Hospital
,
Springfield,
MO
Central Cares Cancer Center, Bolivar, MO
Skaggs Cancer Centers, Branson, MO
For more information about this clinical trial, click here.